Manufacturers Life Insurance Company, The Igm Biosciences, Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 74,612 shares of IGMS stock, worth $489,454. This represents 0.0% of its overall portfolio holdings.

Number of Shares

74,612

Previous 68,929 8.24%

Holding current value

$489,454

Previous $473,000 160.89%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.28 - $17.68 $35,689 - $100,475	5,683 Added 8.24%	74,612 $1.23 Million
Q2 2024 Aug 14, 2024	SELL	$6.51 - $11.47 $10,233 - $18,030	-1,572 Reduced 2.23%	68,929 $473,000
Q1 2024 May 14, 2024	BUY	$8.68 - $17.36 $187,132 - $374,264	21,559 Added 44.05%	70,501 $680,000
Q2 2023 Aug 11, 2023	BUY	$8.86 - $14.0 $99,993 - $158,004	11,286 Added 29.97%	48,942 $451,000
Q4 2022 Aug 11, 2023	BUY	$15.45 - $26.02 $540 - $910	35 Added 0.09%	37,656 $640,000
Q4 2022 Feb 13, 2023	BUY	$15.45 - $26.02 $540 - $910	35 Added 0.09%	37,656 $640,000
Q3 2022 Aug 11, 2023	SELL	$15.42 - $27.01 $2,482 - $4,348	-161 Reduced 0.43%	37,621 $855,000
Q3 2022 Nov 03, 2022	SELL	$15.42 - $27.01 $2,482 - $4,348	-161 Reduced 0.43%	37,621 $746,000
Q2 2022 Aug 11, 2023	BUY	$13.27 - $25.5 $84,450 - $162,282	6,364 Added 20.26%	37,782 $681,000
Q2 2022 Aug 15, 2022	BUY	$13.27 - $25.5 $84,450 - $162,282	6,364 Added 20.26%	37,782 $695,000
Q1 2022 Aug 11, 2023	SELL	$13.42 - $29.73 $83,713 - $185,455	-6,238 Reduced 16.57%	31,418 $839,000
Q1 2022 May 20, 2022	BUY	$13.42 - $29.73 $421,629 - $934,057	31,418 New	31,418 $814,000
Q4 2021 Feb 16, 2022	SELL	$27.59 - $66.39 $131,024 - $315,286	-4,749 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$65.76 - $90.65 $29,460 - $40,611	-448 Reduced 8.62%	4,749 $312,000
Q2 2021 Aug 12, 2021	BUY	$57.98 - $96.6 $28,932 - $48,203	499 Added 10.62%	5,197 $432,000
Q1 2021 May 03, 2021	SELL	$71.56 - $121.23 $2,289 - $3,879	-32 Reduced 0.68%	4,698 $360,000
Q4 2020 Feb 12, 2021	BUY	$47.41 - $115.03 $189 - $460	4 Added 0.08%	4,730 $418,000
Q2 2020 Aug 10, 2020	BUY	$51.3 - $75.21 $48,837 - $71,599	952 Added 25.23%	4,726 $321,000
Q1 2020 May 15, 2020	BUY	$31.51 - $73.75 $118,918 - $278,332	3,774 New	3,774 $212,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

20.7M

Call Options Held

68K

Put Options Held

52.2K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $190M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Igm Biosciences, Inc. Transaction History